第三代肺癌靶向藥物泰瑞沙獲批，並於4月中旬正式進入中國市場

来源: hz82000 于 2017-06-05 06:37:31 [博客] [旧帖] [给我悄悄话] 本文已被阅读：次

WENXUECITY.COM does not represent or guarantee the truthfulness, accuracy, or reliability of any of communications posted by other users.

Change Ad Consent